Consultations
On this page you will find proposed changes that are currently going through the NTAG approval process. You can comment on current proposals via the links in the table below.
Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the NTAG subgroups, and used to inform the final version that is presented for approval in the NENC.
All comments will be reviewed but please do not expect a personal reply as due to the high number of consultations and volume of comments received we do not routinely reply to all comments. A record of the response to each comment received is kept and is reviewed by NTAG. It is important to include any relevant evidence to back up any suggestions and please keep comments concise where possible.
All comments received will shared unedited with the authors/working group who are developing the document to support the production of a final draft for approval.
Please direct any questions to the secretariat at nuth.nyrdtc.rxsupp@nhs.net.
| Title | Information | Feedback | End Date |
|---|---|---|---|
|
NENC Methylphenidate for patients within Paediatric Oncology Shared Care Protocol [link removed - consultation closed] |
The North East and North Cumbria (NENC) Clinical Guidelines & Pathways Group are seeking system-wide views on adoption of this draft guideline in the attached consultation document. This consultation closes at 5pm on Wednesday 14 October. | [link removed - consultation closed] | October 14th, 2026 |
| 30 day TA - daratumumab for multiple myeloma | North East and North Cumbria (NENC) ICB is seeking system-wide views on implementation of this 30 day NICE TA for daratumumab with bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma. This consultation closes at 5pm on Monday 19th October. | Feedback Form | October 19th, 2026 |
| 30 day TA - mirdametinib for plexiform neurofibromas | North East and North Cumbria (NENC) ICB is seeking system-wide views on implementation of this 30 day NICE TA for mirdametinib for treating symptomatic and inoperable plexiform neurofibromas. This consultation closes at 5pm on Monday 19th October. | Feedback Form | October 19th, 2026 |
| NENC Formulary Working Group actions - September 2026 | The North East and North Cumbria (NENC) Formulary Working Group are seeking system-wide views on adoption of the actions proposed at their September 2026 meeting. This consultation closes at 5pm on Monday 2nd November. | Feedback Form | November 2nd, 2026 |
| NENC Wound Management Formulary | North East and North Cumbria (NENC) ICB is seeking system-wide views on adoption of the draft wound management formulary in the attached consultation document. This consultation closes at 5pm on Monday 2nd November. | Feedback Form | November 2nd, 2026 |
|
NENC NICE TAs - July 2026 [link removed - consultation closed] |
North East and North Cumbria (NENC) ICB is seeking system-wide views on adoption of the proposed NICE technology appraisals in the attached consultation document. This consultation closes at 5pm on Monday 21st September. | [link removed - consultation closed] | September 21st, 2026 |
|
NENC NICE TAs - August 2026 [link removed - consultation closed] |
North East and North Cumbria (NENC) ICB is seeking system-wide views on adoption of the proposed NICE technology appraisals in the attached consultation document. This consultation closes at 5pm on Tuesday 6th October. | [link removed - consultation closed] | October 6th, 2026 |